×
About 14,695 results

ALLMedicine™ Cytomegalovirus Center

Research & Reviews  5,528 results

Feasibility and acceptability of targeted salivary cytomegalovirus screening through un...
https://doi.org/10.1111/jpc.15705
Journal of Paediatrics and Child Health; Webb E, Gillespie AN et. al.

Sep 15th, 2021 - This study aimed to determine the feasibility and parental acceptability of screening for congenital cytomegalovirus (cCMV) through saliva polymerase chain reaction in infants who did not pass their newborn hearing screening. Additionally, the uti...

A gastric outlet thickened mucosal fold associated with cytomegalovirus infection in an...
https://doi.org/10.1080/20469047.2021.1967626
Paediatrics and International Child Health; Tangirala S, Amboiram P et. al.

Sep 15th, 2021 - Non-bilious vomiting in preterm neonates discharged from neonatal intensive care units is a common complaint and is often associated with benign conditions such as gastro-oesophageal reflux. A neonate of 27 weeks gestation who presented later with...

Congenital cytomegalovirus infection and the risk of hearing loss in childhood: A PRISM...
https://doi.org/10.1097/MD.0000000000027057
Medicine Liu PH, Hao JD et. al.

Sep 14th, 2021 - Congenital cytomegalovirus (cCMV) infection is the most common cause of childhood hearing loss (HL), although the strength of this association remains limited and inconclusive. Thus, the purpose of this study was to summarize evidence regarding th...

Cytomegalovirus reactivation in esophageal cancer patients receiving chemoradiotherapy:...
https://doi.org/10.1002/cam4.4269
Cancer Medicine; Kitagawa K, Okada H et. al.

Sep 14th, 2021 - Although rare, cytomegalovirus (CMV) reactivation can be lethal in patients with cancer. However, the criteria for the prevention of cytomegalovirus reactivation during cancer treatment are unclear. This study aimed to identify factors associated ...

Viruses in colorectal cancer.
https://doi.org/10.1002/1878-0261.13100
Molecular Oncology; Marongiu L, Allgayer H

Sep 14th, 2021 - Increasing evidence suggests that microorganisms might represent at least highly interesting co-factors in colorectal cancer (CRC) oncogenesis and progression. Still, associated mechanisms, specifically in colonocytes and their microenvironmental ...

see more →

Guidelines  8 results

Guideline No. 420: Cytomegalovirus Infection in Pregnancy.
https://doi.org/10.1016/j.jogc.2021.05.015
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Boucoiran I, Yudin M et. al.

Jun 6th, 2021 - To provide an update on current recommendations for cytomegalovirus (CMV) infection during pregnancy. The objectives of this guideline are: TARGET POPULATION: Patients of child-bearing age, pregnant patients, and patients planning a pregnancy. The...

The Third International Consensus Guidelines on the Management of Cytomegalovirus in So...
https://doi.org/10.1097/TP.0000000000002191
Transplantation Kotton CN, Kumar D et. al.

Mar 30th, 2018 - Despite recent advances, cytomegalovirus (CMV) infections remain one of the most common complications affecting solid organ transplant recipients, conveying higher risks of complications, graft loss, morbidity, and mortality. Research in the field...

No. 240-Cytomegalovirus Infection in Pregnancy.
https://doi.org/10.1016/j.jogc.2017.11.018
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Yinon Y, Farine D et. al.

Feb 16th, 2018 - To review the principles of prenatal diagnosis of congenital cytomegalovirus (CMV) infection and to describe the outcomes of the affected pregnancies. Effective management of fetal infection following primary and secondary maternal CMV infection d...

Practice bulletin no. 151: Cytomegalovirus, parvovirus B19, varicella zoster, and toxop...
https://doi.org/10.1097/01.AOG.0000466430.19823.53
Obstetrics and Gynecology;

May 23rd, 2015 - Practice bulletin no. 151: Cytomegalovirus, parvovirus B19, varicella zoster, and toxoplasmosis in pregnancy.|2015||diagnosis,therapy,transmission,diagnosis,therapy,transmission,diagnosis,therapy,transmission,diagnosis,therapy,prevention & control...

Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269340
Annals of Oncology : Official Journal of the European Soc... Maschmeyer G, Carratalà J et. al.

May 17th, 2014 - Up to 25% of patients with profound neutropenia lasting for >10 days develop lung infiltrates, which frequently do not respond to broad-spectrum antibacterial therapy. While a causative pathogen remains undetected in the majority of cases, Aspergi...

see more →

Drugs  72 results see all →

Clinicaltrials.gov  7 results

Exercise and Total Viral Immunity
https://clinicaltrials.gov/ct2/show/NCT05019456

Aug 24th, 2021 - Acute upper and lower respiratory tract infections (RTI) due to respiratory viruses, such as, respiratory syncytial virus (RSV), influenza, parainfluenza virus (PIV) and human metapneumovirus (hMPV) are a major public health problem. During the 20...

Study to Evaluate Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC)
https://clinicaltrials.gov/ct2/show/NCT04390113

Jul 28th, 2021 - The study hypothesis is that the administration of ALVR105 to patients with virus-associated HC will demonstrate superiority for the time to resolution of HC (as measured by resolution of macroscopic hematuria) compared to patients treated with pl...

A Pilot Study Comparing the Use of Low-target Versus Conventional Target Advagraf
https://clinicaltrials.gov/ct2/show/NCT01265537

Feb 11th, 2020 - Purpose This study has been designed to test whether using Thymoglobulin with low dose tacrolimus and early steroid withdrawal will minimize both kidney rejection and the development of new onset diabetes after transplant (NODAT). Justification Ex...

Treating Kidney Donors With Valganciclovir to Reduce Viral Transmission to Recipients
https://clinicaltrials.gov/ct2/show/NCT01329185

Nov 1st, 2019 - The potency of new immunosuppressive agents has reduced the risk of the body's immune system rejecting a transplanted kidney. However, this has come with a price. Kidney transplant recipients now face a higher risk of serious infections and relate...

Noninvasive Evaluation of Cardiac Allograft Vasculopathy
https://clinicaltrials.gov/ct2/show/NCT01305382

Nov 15th, 2016 - Cardiac transplantation has become the established treatment of choice for eligible patients with end-stage heart failure. Cardiac allograft vasculopathy (CAV) is a major and potentially preventable limitation to long-term survival in cardiac tran...

see more →

News  262 results

Novel Combinations Being Investigated for mCRC Treatment
https://www.onclive.com/view/novel-combinations-being-investigated-for-mcrc-treatment

Jun 4th, 2021 - Tanios S. Bekaii-Saab, MD: All of this excitement about immune therapy led us down the path to the question of, can we take microsatellite-stable tumors and make them hot, make them merely inflamed? Cathy, what do we know about the data? We've see...

Antiviral May Improve Hearing Loss in Congenital CMV
https://www.medscape.com/viewarticle/952258

Jun 2nd, 2021 - Infants with isolated sensorineural hearing loss as a result of congenital cytomegalovirus (cCMV) infection may benefit from treatment with valganciclovir, according to results from the CONCERT nonrandomized trial. Subjects were found through the ...

Ocular Abnormalities Not Likely in Newborns of SARS-CoV-2-infected Mothers
https://www.medscape.com/viewarticle/949001

Apr 9th, 2021 - (Reuters Health) - Unlike pathogens such as Cytomegalovirus and Zika, SARS-CoV-2 is not likely to cause ocular problems in newborns whose mothers were infected with the virus during pregnancy, a new case series suggests. In an analysis of data fro...

Allogenic CAR T-Cell Therapy in Lymphoma
https://www.onclive.com/view/allogenic-car-t-cell-therapy-in-lymphoma

Apr 2nd, 2021 - Transcript: David Miklos, MD:In this analysis of the sponsored Allogene [Therapeutics] work, which has an interesting history, these were the founders of Kite who then moved on to a new project. Today, we’re seeing the first published presente...

Expert Highlights Advances in DRESS
https://www.medscape.com/viewarticle/944939

Jan 29th, 2021 - Mounting evidence suggests it's a mistake to reject the diagnosis of drug reaction with eosinophilia and systemic symptoms, or DRESS, simply because the interval between initiating a drug and symptom onset is less than 15 days, Sarah Walsh, MD, sa...

see more →

Patient Education  1 results see all →